Otoharmonics—a Portland, Ore-based company that developed the Levo System to treat tinnitus symptoms—announced that the Levo System has been awarded the top prize in the Digital Health Products and Mobile Medical Apps category of the 19th Annual Medical Design Excellence Awards (MDEA) competition. The 2017 winners were announced at the 2017 MDEA Ceremony on June 13 at the Jacob K. Javits Convention Center in New York City.
Utilizing an FDA-cleared, evidence-based approach, the Levo System offers a patented method to provide personalized sound therapy for tinnitus while sleeping, according to the company. The Levo System is currently available throughout the United States, Canada, and the UK.
“This achievement could not have been possible without the collective effort of everyone on the Otoharmonics team,” said Brenda Edin, chief marketing officer of Otoharmonics. “More than a win for our company, this is a win for the tinnitus patients we serve.”
The 2017 MDEA Juror Panel selected the winning products based on design and engineering innovation; function and user-related innovation; patient benefits; business benefits; and overall benefit to the healthcare system. The MDEA jury is comprised of a balance of practicing doctors, nurses, and technicians alongside industrial designers, engineers, manufacturers, and human factors experts.